Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2010
12/22/2010CN101424610B Nitrogen austenite steel microstructure predicting method
12/22/2010CN101419145B Synchronization double-action flat-pushing hydraulic clamp
12/22/2010CN101276393B Method and system for acquiring bar code information of biochemistry instrument
12/22/2010CN101271103B Experimental device for concrete multifactor permanent stability under co-action of pulling stress and surroundings
12/22/2010CN101269203B Quality control testing method for brain-invigorating and heart-soothing capsule
12/22/2010CN101261242B Water quality toxicity biosensor microorganism electrode preparation method
12/22/2010CN101216478B Explosive friction sensitivity instrument
12/22/2010CN101178395B Non-contact type rock three-way shrinkage test device
12/22/2010CN101078721B Reagent and method for classifying leucocyte
12/22/2010CN101059487B Immunoaffinity chromatography column and its uses in purifying quinolone analogue drug
12/22/2010CN101042390B Geotechnical engineering physical simulation multifunctional tester with adjustable two-dimension or three-dimensional of model
12/21/2010US7856325 Automatic threshold setting for quantitative polymerase chain reaction
12/21/2010US7856324 Automatic threshold setting for quantitative polymerase chain reaction
12/21/2010US7856323 Method for analyzing blood for lipoprotein components
12/21/2010US7856321 Modeling biological effects of molecules using molecular property models
12/21/2010US7856320 Systems for gene expression array analysis
12/21/2010US7856319 Diagnosis method of alcoholic steato-hepatitis using biochemical markers
12/21/2010US7856317 Systems and methods for constructing genomic-based phenotypic models
12/21/2010US7855356 Determination of chemical empirical formulas of unknown compounds using accurate ion mass measurement of all isotopes
12/21/2010US7855293 Fluorescent dyes such as 2-(4-acetanilino-1,3-butadieneyl)-3-spiro-1'-cyclohexan-1-(4-sulfobutyl)-3H -indolium hydroxide metal salts which couple biological materials without loss of fluorescence due to self-quenching
12/21/2010US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy
12/21/2010US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis
12/21/2010US7855276 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells
12/21/2010US7855270 Genetically engineered receptor for use in the detection and analysis of protein binding activity
12/21/2010US7855167 In vivo screening of protein-protein interactions with protein-fragment complementation assays
12/21/2010US7855081 Methods of detecting RF interference in breath ethanol testing
12/21/2010US7855080 Fingerprint analysis for a plurality of oligonucleotides
12/21/2010US7855079 Methods for assaying percentage of glycated hemoglobin
12/21/2010US7855075 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/21/2010US7855074 Artificial immune system: methods for making and use
12/21/2010US7855073 Cells containing a nanopatch sensor in their membrane
12/21/2010US7855072 System for detecting protease
12/21/2010US7855068 For detecting a target cell in a sample of untreated or substantially untreated whole blood
12/21/2010US7855063 Partially deglycosylated glucocerebrosidase polypeptide and crystals thereof
12/21/2010US7855057 Includes a preselected fragmentation scheme to generate target peptides and an identification scheme that employs using more than one epitope on each target peptide to bind more than one binding agent; detecting unambiguously the presence of one or more of a plurality of target protein isoforms
12/21/2010US7855056 Antibody against tumor specific antigen as target
12/21/2010US7855027 Methods and apparatus for breath alcohol testing
12/21/2010US7854959 Preparing selfassembled,graded, monomolecular films for use as solid supports in analysis of cell migration and motility; high throughput assay
12/21/2010US7854945 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils
12/21/2010US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
12/21/2010US7854890 Analytical tool, analytical tool pack, cartridge including plurality of packs, method of making analytical tool pack, analyzer, and mechanism for taking out object
12/21/2010US7854159 Sensor and methods for measuring of concentrations of components in a liquid
12/21/2010CA2602646C Methods for using light reflection patterns to determine location of pith and curvature of the annual ring
12/21/2010CA2567738C The use of cardiac hormones for diagnosing the risk of suffering from a cardiovascular complication as a consequence of cardiotoxic medication
12/21/2010CA2528114C Monoclonal antibodies specific for buprenorphine and metabolites thereof
12/21/2010CA2523297C Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte, and utilization of same
12/21/2010CA2490724C Method for the diagnosis and prognosis of malignant diseases
12/21/2010CA2480466C Detection and/or monitoring of synuclein-related diseases
12/21/2010CA2476696C Methods of diagnosing liver fibrosis
12/21/2010CA2463323C Nanoparticles having oligonucleotides attached thereto and uses therefor
12/21/2010CA2457145C Assay method for alzheimer's disease
12/21/2010CA2451909C High throughput assays for the proteolytic activities of clostridial neurotoxins
12/21/2010CA2437084C High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation
12/21/2010CA2411981C Urokinase inhibitors
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/21/2010CA2388595C Methods and devices for identifying patterns in biological systems and methods for uses thereof
12/21/2010CA2369895C High affinity inhibitors for target validation and uses thereof
12/21/2010CA2356286C An assay to detect a binding partner
12/21/2010CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/21/2010CA2318459C Neutralization of polycations in a chromatographic device for whole blood use
12/21/2010CA2307316C Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
12/21/2010CA2305275C Apparatus and method for analyte detection
12/21/2010CA2220753C Novel peptides and compositions which modulate apoptosis
12/21/2010CA2199821C Cloning and regulation of an endothelial cell protein c/activated protein c receptor
12/16/2010WO2010144908A2 Mammalian genes involved in tularemia and other infections
12/16/2010WO2010144904A1 Use of lcat for treating anemia and red blood cell dysfunction
12/16/2010WO2010144876A1 Methods to detect cancer in animals
12/16/2010WO2010144859A2 Devices and methods for automated sample preparation, assay, and analysis
12/16/2010WO2010144846A2 Gastrointestinal disease or disorder imaging and treatment
12/16/2010WO2010144808A2 Identification of dsg-3 as a biomarker for the detection of metastasis in lymph nodes
12/16/2010WO2010144799A2 Methods and compositions for diagnostic assays for measuring cell mediated immune response
12/16/2010WO2010144747A2 Flexible pouch and cartridge with fluidic circuits
12/16/2010WO2010144745A2 Sheath flow devices and methods
12/16/2010WO2010144711A2 Immunological targeting of pathological tau proteins
12/16/2010WO2010144695A1 A highly sensitive method for detection of viral hiv dna remaining after antiretroviral therapy of aids patients
12/16/2010WO2010144634A1 Method and system to detect, diagnose, and monitor the progression of alzheimer's disease
12/16/2010WO2010144612A1 Compositions and methods for optimizing drug hydrophobicity and drug delivery to cells
12/16/2010WO2010144507A2 Rapid detection of cerebrospinal fluid, methods and systems therefore
12/16/2010WO2010144482A2 Systems and methods for the identification of compounds in medical fluids using admittance spectroscopy
12/16/2010WO2010144441A1 Method and assembly for determining the temperature of a test sensor
12/16/2010WO2010144358A1 Highly sensitive biomarker panels
12/16/2010WO2010144348A2 Reduction of antibiotic activity or concentration in biological samples using molecularly imprinted polymers
12/16/2010WO2010144324A2 Use of stamp related molecules in the diagnosis and inhibition of ovarian cancer cells
12/16/2010WO2010144313A2 Non-invasive monitoring of blood metabolite levels
12/16/2010WO2010144192A1 Prognosis indicators for solid human tumors
12/16/2010WO2010144157A1 Molecular imprinted nanosensors
12/16/2010WO2010144150A2 Real-time analytical methods and systems
12/16/2010WO2010144053A1 Method for determining protein-nucleic acid interaction
12/16/2010WO2010144005A1 On-demand gas regulator for gas analyzer calibration
12/16/2010WO2010143983A1 Assays for serological detection of syphilis
12/16/2010WO2010143956A1 Method for predicting glycaemic response and use thereof
12/16/2010WO2010143953A1 Method for determining weights of eggs, and apparatus
12/16/2010WO2010143799A1 Portable material analysis system
12/16/2010WO2010143423A1 Method for test on diabetic nephropathy
12/16/2010WO2010143422A1 Test method on renal diseases
12/16/2010WO2010143010A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy
12/16/2010WO2010142996A1 Therapeutic agent and assay
12/16/2010WO2010142974A1 mCPP IMMUNOASSAY
12/16/2010WO2010142963A1 Methods of signal generation and signal localization for improvement of signal readability in solid phase based bioassays
12/16/2010WO2010142960A1 Signal amplification microspheres, their use in one-step and multi-step analytical amplification procedures and methods for their production
1 ... 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 ... 3937